Author: Moreira-Soto, Andres; Arguedas, Mauricio; Brenes, Hebleen; Buján, Willem; Corrales-Aguilar, Eugenia; DÃaz, Cecilia; Echeverri, Ann; Flores-DÃaz, Marietta; Gómez, Aarón; Hernández, Andrés; Herrera, MarÃa; León, Guillermo; Macaya, Román; Kühne, Arne; Molina-Mora, José Arturo; Mora, Javier; Sanabria, Alfredo; Sánchez, Andrés; Sánchez, Laura; Segura, Ãlvaro; Segura, Eduardo; Solano, Daniela; Soto, Claudio; Stynoski, Jennifer L.; Vargas, Mariángela; Villalta, Mauren; Reusken, Chantal B E M; Drosten, Christian; Gutiérrez, José MarÃa; Alape-Girón, Alberto; Drexler, Jan Felix
Title: High efficacy of therapeutic equine hyperimmune antibodies against SARS-CoV-2 variants of concern Cord-id: bf6vjbu0 Document date: 2021_6_14
ID: bf6vjbu0
Snippet: SARS-CoV-2 variants of concern (VoC) show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies. We tested therapeutic equine polyclonal antibodies (pAbs) against four VoC (alpha, beta, epsilon and gamma). We show that equine pAbs efficiently neutralize VoC, suggesting they are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.
Document: SARS-CoV-2 variants of concern (VoC) show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies. We tested therapeutic equine polyclonal antibodies (pAbs) against four VoC (alpha, beta, epsilon and gamma). We show that equine pAbs efficiently neutralize VoC, suggesting they are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date